| Literature DB >> 28419225 |
Nina Persson1, Nicolai Stuhr-Hansen1, Christian Risinger1, Stefan Mereiter2,3,4, António Polónia2,3,5, Karol Polom6, András Kovács1,7, Franco Roviello6, Celso A Reis2,3,4,8, Charlotte Welinder9,10, Lena Danielsson7, Bo Jansson9, Ola Blixt1.
Abstract
Here, we introduce a novel scFv antibody, G2-D11, specific for two adjacent Tn-antigens (GalNAc-Ser/Thr) binding equally to three dimeric forms of the epitope, Ser-Thr, Thr-Thr and Thr-Ser. Compared to other anti-Tn reagents, the binding of G2-D11 is minimally influenced by the peptide structure, which indicates a high degree of carbohydrate epitope dominance and a low influence from the protein backbone. With a high affinity (KDapp = 1.3 × 10-8 M) and no cross-reactivity to either sialyl-Tn epitope or blood group A antigens, scFv G2-D11 is an excellent candidate for a well-defined anti-Tn-antigen reagent. Detailed immunohistochemical evaluation of tissue sections from a cohort of 80 patients with gastric carcinoma showed in all cases positive tumor cells. The observed staining was localized to the cytoplasm and in some cases to the membrane, whereas the surrounding tissue was completely negative demonstrating the usefulness of the novel Tn-antigen binding antibody.Entities:
Keywords: N-acetylgalactosamine (GalNAc); Tn-antigen; gastric cancer; glycosylation; scFv; solid-phase peptide synthesis
Mesh:
Substances:
Year: 2017 PMID: 28419225 DOI: 10.1093/glycob/cwx033
Source DB: PubMed Journal: Glycobiology ISSN: 0959-6658 Impact factor: 4.313